NASDAQ : ANIP

ANI Pharmaceuticals, Inc.

$82.69 USD

$1.87 (2.31%)

Volume
69.18K
Average Volume
345.21K
Market Capitalization
$1.88B
P/E Ratio
20.12
Dividend Yield
0.00%
Price Target
$94.00
Year High
$99.50
Year Low
$62.61
Day High
—
Day Low
—
Payout Ratio
$0.01
Current Ratio
$3.12

ANIP Estimated and Actual Revenue by Quarter

ANIP Estimated and Actual EPS by Quarter

ANIP Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 3 142.63M 149.39M 145.13M 138.93M 145.52M 141.37M
2027-09-30 2 134.85M 141.24M 137.22M 131.35M 137.58M 133.66M
2027-06-30 2 129.18M 135.31M 131.45M 125.83M 131.8M 128.04M
2027-03-31 3 107.11M 112.19M 108.99M 104.33M 109.28M 106.16M
2026-12-31 3 132.13M 138.39M 134.45M 128.7M 134.8M 130.96M
2026-09-30 4 121.03M 124.1M 122.54M 117.89M 120.88M 119.37M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 3 75.75M 80.45M 77.49M 129.77M 135.92M 132.05M
2027-09-30 2 64.92M 68.95M 66.41M 122.69M 128.51M 124.85M
2027-06-30 2 56.62M 60.13M 57.92M 117.54M 123.11M 119.6M
2027-03-31 3 39.53M 41.98M 40.44M 97.45M 102.07M 99.16M
2026-12-31 3 60.37M 64.11M 61.76M 120.21M 125.92M 122.33M
2026-09-30 4 51.04M 56.64M 53.95M 110.12M 112.91M 111.5M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 3 345.08M 361.45M 351.15M 1 3.51621 3.73419 3.597
2027-09-30 2 326.26M 341.74M 332M 1 3.01343 3.20024 3.08267
2027-06-30 2 312.55M 327.38M 318.05M 1 2.62795 2.79086 2.68833
2027-03-31 3 259.14M 271.44M 263.7M 1 1.83484 1.94859 1.877
2026-12-31 3 319.68M 334.84M 325.3M 1 2.80219 2.9759 2.86657
2026-09-30 4 292.84M 300.26M 296.49M 5 2.36906 2.62883 2.50414